Report Summary
Eternity Insights can provide a deep dive research report highlighting the market and competitive in-telligence across the key segments of the market. The report also considers the impact of COVID-19 on the global Cancer Immunotherapy Drug Discovery Outsourcing market. The report considers 2018-2020 historic period, 2021 as base year, and 2022-2028 as forecast period. The report includes quantitative analysis of the market supported by the mar-ket drivers, challenges, and trends to accurately map the market scenario and competition.
Cancer Immunotherapy Drug Discovery Outsourcing market report is based on robust research methodology designed using blend of research ap-proaches developed using secondary/desk research and validated through the primary research and expert insights. Eternity Insights also uses paid data bases such as FACIVA, Hoovers, and other bench-marking and forecasting tools to provide accurate statistical analysis of supply and demand trends.
To learn more about this report
Key Research Highlights: Market Drivers
The Cancer Immunotherapy Drug Discovery Outsourcing market is estimated to expand at a considerable growth rate during the forecast period ow-ing to increasing prevalence of venous diseases and increasing new product approvals to cater this demand. Rise in the awareness about the diseases, increasing importance of early diagnosis, and growing spending on chronic diseases are poised to boost the market growth. Moreover, the key players in the market are investing in research and development of technologically advanced products leading to increased utilization of the Cancer Immunotherapy Drug Discovery Outsourcing products across developed and developing countries of the world.
Key Research Highlights: Market Restrains
Limited awareness about the diseases, high cost of products, low economical condition, and lack of favorable insurance systems restricts the adoption of Cancer Immunotherapy Drug Discovery Outsourcing products across developing regions of the globe. However, launch of new products with low cost and increasing efforts for market penetration in these regions can offer lucrative growth opportunities for the players in the Cancer Immunotherapy Drug Discovery Outsourcing market.
To learn more about this report
Key Research Highlights: Trends
Increasing research and development spending on Cancer Immunotherapy Drug Discovery Outsourcing development has been the leading industry trend of Cancer Immunotherapy Drug Discovery Outsourcing market
The leading players in the market are focused on developing products which are cost effective and high quality to tap the huge unaddressed opportunities in the developing regions. This can be wit-nessed from the increasing spending on research and development and growing number of new product approvals.
Global Cancer Immunotherapy Drug Discovery Outsourcing Market Size, 2018-2028 (USD MILLION)
To learn more about this report
Market Segmentation
| Report Attributes |
Details |
| The market size value in 2021 |
USD XX.XX Million |
| CAGR (2021 - 2028) |
XX.XX % |
| The Revenue forecast in 2028 |
USD XX.XX Million |
| Base year for estimation |
2021 |
| Historical data |
2018-2019 |
| Forecast period |
2022-2028 |
| Quantitative units |
- Revenue in USD Million
- CAGR from 2021 to 2028
|
| Report coverage |
Revenue forecast, company ranking, competitive landscape, growth factors, and trends |
| Segments covered |
By Type Outlook, Application Outlook, Regional Outlook |
| By Type Outlook |
Monoclonal Antibodies, Immunomodulators, Oncolytic Viral Therapies and Cancer Vaccines, Other |
| By Application Outlook |
Lung, Breast, Colorectal, Melanoma, Prostate, Head and Neck, Ovarian, Pancreatic |
| Regional scope |
North America, Europe, Asia Pacific, Latin America, Middle East & Africa |
| Country scope |
U.S., Canada, U.K., Germany, France, BENELUX, China, India, Japan, South Korea, Brazil, Saudi Arabia, UAE, Turkey |
| Key companies profiled |
Aquila BioMedical, BPS Bioscience, Inc., Celentyx Ltd, Crown Bioscience, Inc., DiscoverX Corporation, Explicyte, Genscript Biotech Corporation, HD Biosciences Co., Horizon Discovery Group PLC, ImmunXperts SA, Molecular Imaging, Inc., Promega Corporation,Personalis, Inc., STC Biologics |
| Customization Available |
Yes, the report can be tailored to meet your specific requirements. |
Key Market Players
- Aquila BioMedical
- BPS Bioscience
- Inc.
- Celentyx Ltd
- Crown Bioscience
- Inc.
- DiscoverX Corporation
- Explicyte
- Genscript Biotech Corporation
- HD Biosciences Co.
- Horizon Discovery Group PLC
- ImmunXperts SA
- Molecular Imaging
- Inc.
- Promega Corporation
- Personalis
- Inc.
- STC Biologics
Cancer Immunotherapy Drug Discovery Outsourcing Market, By Type
- Monoclonal Antibodies
- Immunomodulators
- Oncolytic Viral Therapies and Cancer Vaccines
- Other
Cancer Immunotherapy Drug Discovery Outsourcing Market, By Application
- Lung
- Breast
- Colorectal
- Melanoma
- Prostate
- Head and Neck
- Ovarian
- Pancreatic
Key Benefits To The Stake Holders
- Qualitative and quantitative analysis of the market based on segmentation involving both economic as well as non-economic factors
- Provision of market value (USD Billion) and volume (Tons) data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry with respect to recent developments (which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Table Of Contents
Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Cancer Immunotherapy Drug Discovery Outsourcing Market Size Growth Rate by Type (2017-2027)
1.4.2 Monoclonal Antibodies
1.4.3 Immunomodulators
1.4.4 Oncolytic Viral Therapies and Cancer Vaccines
1.4.5 Other
1.5 Market by Application
1.5.1 Global Cancer Immunotherapy Drug Discovery Outsourcing Market Share by Application (2017-2027)
1.5.2 Lung
1.5.3 Breast
1.5.4 Colorectal
1.5.5 Melanoma
1.5.6 Prostate
1.5.7 Head and Neck
1.5.8 Ovarian
1.5.9 Pancreatic
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Cancer Immunotherapy Drug Discovery Outsourcing Market Size
2.2 Cancer Immunotherapy Drug Discovery Outsourcing Growth Trends by Regions
2.2.1 Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Regions (2017-2027)
2.2.2 Cancer Immunotherapy Drug Discovery Outsourcing Market Share by Regions (2017-2020)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
3 Market Share by Key Players
3.1 Cancer Immunotherapy Drug Discovery Outsourcing Market Size by by Players
3.1.1 Global Cancer Immunotherapy Drug Discovery Outsourcing Revenue by by Players (2017-2020)
3.1.2 Global Cancer Immunotherapy Drug Discovery Outsourcing Revenue Market Share by by Players (2017-2020)
3.1.3 Global Cancer Immunotherapy Drug Discovery Outsourcing Market Concentration Ratio (CR5 and HHI)
3.2 Cancer Immunotherapy Drug Discovery Outsourcing Key Players Head office and Area Served
3.3 Key Players Cancer Immunotherapy Drug Discovery Outsourcing Product/Solution/Service
3.4 Date of Enter into Cancer Immunotherapy Drug Discovery Outsourcing Market
3.5 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type and Application
4.1 Global Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Type (2017-2020)
4.2 Global Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Application (2017-2020)
5 United States
5.1 United States Cancer Immunotherapy Drug Discovery Outsourcing Market Size (2017-2020)
5.2 Cancer Immunotherapy Drug Discovery Outsourcing Key Players in United States
5.3 United States Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Type
5.4 United States Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Application
6 Europe
6.1 Europe Cancer Immunotherapy Drug Discovery Outsourcing Market Size (2017-2020)
6.2 Cancer Immunotherapy Drug Discovery Outsourcing Key Players in Europe
6.3 Europe Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Type
6.4 Europe Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Application
7 China
7.1 China Cancer Immunotherapy Drug Discovery Outsourcing Market Size (2017-2020)
7.2 Cancer Immunotherapy Drug Discovery Outsourcing Key Players in China
7.3 China Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Type
7.4 China Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Application
8 Japan
8.1 Japan Cancer Immunotherapy Drug Discovery Outsourcing Market Size (2017-2020)
8.2 Cancer Immunotherapy Drug Discovery Outsourcing Key Players in Japan
8.3 Japan Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Type
8.4 Japan Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Application
9 Southeast Asia
9.1 Southeast Asia Cancer Immunotherapy Drug Discovery Outsourcing Market Size (2017-2020)
9.2 Cancer Immunotherapy Drug Discovery Outsourcing Key Players in Southeast Asia
9.3 Southeast Asia Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Type
9.4 Southeast Asia Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Application
10 India
10.1 India Cancer Immunotherapy Drug Discovery Outsourcing Market Size (2017-2020)
10.2 Cancer Immunotherapy Drug Discovery Outsourcing Key Players in India
10.3 India Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Type
10.4 India Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Application
11 Central & South America
11.1 Central & South America Cancer Immunotherapy Drug Discovery Outsourcing Market Size (2017-2020)
11.2 Cancer Immunotherapy Drug Discovery Outsourcing Key Players in Central & South America
11.3 Central & South America Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Type
11.4 Central & South America Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Application
12 International Players Profiles
12.1 Aquila BioMedical
12.1.1 Aquila BioMedical Company Details
12.1.2 Company Description and Business Overview
12.1.3 Cancer Immunotherapy Drug Discovery Outsourcing Introduction
12.1.4 Aquila BioMedical Revenue in Cancer Immunotherapy Drug Discovery Outsourcing Business (2017-2020)
12.1.5 Aquila BioMedical Recent Development
12.2 BPS Bioscience, Inc.
12.2.1 BPS Bioscience, Inc. Company Details
12.2.2 Company Description and Business Overview
12.2.3 Cancer Immunotherapy Drug Discovery Outsourcing Introduction
12.2.4 BPS Bioscience, Inc. Revenue in Cancer Immunotherapy Drug Discovery Outsourcing Business (2017-2020)
12.2.5 BPS Bioscience, Inc. Recent Development
12.3 Celentyx Ltd
12.3.1 Celentyx Ltd Company Details
12.3.2 Company Description and Business Overview
12.3.3 Cancer Immunotherapy Drug Discovery Outsourcing Introduction
12.3.4 Celentyx Ltd Revenue in Cancer Immunotherapy Drug Discovery Outsourcing Business (2017-2020)
12.3.5 Celentyx Ltd Recent Development
12.4 Crown Bioscience, Inc.
12.4.1 Crown Bioscience, Inc. Company Details
12.4.2 Company Description and Business Overview
12.4.3 Cancer Immunotherapy Drug Discovery Outsourcing Introduction
12.4.4 Crown Bioscience, Inc. Revenue in Cancer Immunotherapy Drug Discovery Outsourcing Business (2017-2020)
12.4.5 Crown Bioscience, Inc. Recent Development
12.5 DiscoverX Corporation
12.5.1 DiscoverX Corporation Company Details
12.5.2 Company Description and Business Overview
12.5.3 Cancer Immunotherapy Drug Discovery Outsourcing Introduction
12.5.4 DiscoverX Corporation Revenue in Cancer Immunotherapy Drug Discovery Outsourcing Business (2017-2020)
12.5.5 DiscoverX Corporation Recent Development
12.6 Explicyte
12.6.1 Explicyte Company Details
12.6.2 Company Description and Business Overview
12.6.3 Cancer Immunotherapy Drug Discovery Outsourcing Introduction
12.6.4 Explicyte Revenue in Cancer Immunotherapy Drug Discovery Outsourcing Business (2017-2020)
12.6.5 Explicyte Recent Development
12.7 Genscript Biotech Corporation
12.7.1 Genscript Biotech Corporation Company Details
12.7.2 Company Description and Business Overview
12.7.3 Cancer Immunotherapy Drug Discovery Outsourcing Introduction
12.7.4 Genscript Biotech Corporation Revenue in Cancer Immunotherapy Drug Discovery Outsourcing Business (2017-2020)
12.7.5 Genscript Biotech Corporation Recent Development
12.8 HD Biosciences Co.
12.8.1 HD Biosciences Co. Company Details
12.8.2 Company Description and Business Overview
12.8.3 Cancer Immunotherapy Drug Discovery Outsourcing Introduction
12.8.4 HD Biosciences Co. Revenue in Cancer Immunotherapy Drug Discovery Outsourcing Business (2017-2020)
12.8.5 HD Biosciences Co. Recent Development
12.9 Horizon Discovery Group PLC
12.9.1 Horizon Discovery Group PLC Company Details
12.9.2 Company Description and Business Overview
12.9.3 Cancer Immunotherapy Drug Discovery Outsourcing Introduction
12.9.4 Horizon Discovery Group PLC Revenue in Cancer Immunotherapy Drug Discovery Outsourcing Business (2017-2020)
12.9.5 Horizon Discovery Group PLC Recent Development
12.10 ImmunXperts SA
12.10.1 ImmunXperts SA Company Details
12.10.2 Company Description and Business Overview
12.10.3 Cancer Immunotherapy Drug Discovery Outsourcing Introduction
12.10.4 ImmunXperts SA Revenue in Cancer Immunotherapy Drug Discovery Outsourcing Business (2017-2020)
12.10.5 ImmunXperts SA Recent Development
12.11 Molecular Imaging, Inc.
12.12 Promega Corporation,Personalis, Inc.
12.13 STC Biologics
13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)
14 Analyst's Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details
